Executives from Siemens Healthineers (ETR:SHL) highlighted what they called a “very solid start” to fiscal 2026 in a podcast-style recap of the company’s Q1 2026 reporting and a subsequent virtual ...

Siemens Healthineers announced that it agreed to expand its strategic collaboration with Mayo Clinic to enhance patient care.

Mayo Clinic Siemens expand AI collaboration to enhance imaging and digital twin technologies for neurodegenerative diseases and cancer care.

By Maria Rugamer and Orest Dovhan Feb 5 (Reuters) - Siemens Healthineers posted mixed first‑quarter results on Thursday, ...

An expanded collaboration between the two organizations will focus on prostate cancer and metastatic liver tumors, in addition to certain neurological disorders.

Siemens Healthineers reported good revenue growth and margin expansion in Q2 2024, with strong performance in Imaging, Varian, and Advanced Therapies segments. Despite a recent decline in share price, ...

Revenue grew on a comparable basis as results in its imaging and precision therapy business units offset currency and tariff ...

Siemens Healthineers reported first-quarter operating profit above market expectations on Thursday, as strong margin ...

If you are wondering whether Siemens Healthineers at €40.86 is a bargain or a value trap, this article will help you frame ...

The European tech giant currently has an approximately 67% stake in the medical technology unit. It plans to transfer 30% of Siemens Healthineers shares to Siemens AG shareholders by way of a direct ...

I looked at Siemens Healthineers in my last article back in March, which makes it suitable for an update at this time. Siemens Healthineers remains a solid company to look at for long-term investment ...

Siemens said it would deconsolidate its roughly 67% stake in Siemens Healthineers, positioning itself as a focused technology company. The German industrial conglomerate said Wednesday that it plans ...